InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 266857

Monday, 08/29/2016 5:34:34 PM

Monday, August 29, 2016 5:34:34 PM

Post# of 345756

Agenus was always another puzzle piece, possibly with something that they were not ready to disclose, as their pipeline still shows "undisclosed" partners... could one being with PS Targeting?

Will say one thing, IF there are connections below and then the untimely passings of the late Dr. Thorpe and Dr. Parsa should light up some further investigations




So the puzzle pieces continue to come together... Agenus must disclose their pipeline details sometime soon I would say


Jennifer BuellVice President, Development Operations = Agenus
http://www.cgteurope.com/page.cfm/action=Seminar/libID=1/libEntryID=47

https://www.linkedin.com/in/alexrduncan

---------------

The odds are increasing that Agenus and Peregrine have been in collaborations, as I've been watching this pipeline every so often and yes.... still says "multiple undisclosed"

http://www.agenusbio.com/science/

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News